Patient-reported outcome measures for systemic lupus erythematosus: an expert Delphi consensus to guide implementation in routine care
Expert consensus on Patient-reported outcome Measures (PROMs) for the follow-up in clinical practice in Spain of patients with systemic lupus erythematosus. The present Delphi consensus may provide a roadmap for implementing PROMs, which is key for the management of SLE.
Use of Tirzepatide in adults with Type 2 Diabetes Mellitus: Scientific evidence and practical aspects
Tirzepatide is a novel antidiabetic medication a single-molecule, agonist to the glucose-dependent insulinotropic polypeptide and glucagon-like peptide-1 receptor agonist , approved in the USA and in EU for the treatment of type 2 diabetes mellitus (T2DM) and obesity. Due to the potential novelty represented by incorporating tirzepatide to clinical practice, we aim to review practical […]
Disease and economic burden of poor metabolic and weight control in Type 2 Diabetes in Spain: a systematic literature review
Systematic literature review to gather all available evidence describing the clinical, economic and HRQoL burden of poor metabolic and/or weight control in patients with T2D in Spain
Health-related quality of life in patients living with Wilson disease in Spain: a cross-sectional observational study
Cross-sectional observational study conducted in patients diagnosed of Wilson disease. The results of the study show a high proportion of patients with impairment mainly in the emotional domain. Although many patients are satisfied with the treatment, they feel that they have to take too many tablets daily, which could affect adherence. The study indicates that […]
Defining a standard set of health outcomes for patients with relapsing-remitting multiple sclerosis
An expert consensus on the definition of a standardised set of health outcome variables for managing patients with relapsing-remitting multiple sclerosis. This set includes all relevant variables for both healthcare professionals and patients, the instruments needed to collect them, and the measurement frequency.
Cost-effectiveness analysis of abrocitinib compared with other systemic treatments for severe atopic dermatitis in Spain
Atopic dermatitis (AD) is a chronic, inflammatory skin disease characterized by itchy, painful, and dry skin. Despite the great number of available therapies, economic evaluations are needed to provide evidence on their cost-efficiency to assist the National Health System (NHS) in decision-making. The objective of this study is to evaluate the cost-effectiveness of abrocitinib (200mg) […]
Patient-Reported Outcome Measures in severe asthma: an expert consensus
An expert consensus on the most relevant Patient Reported Outcomes (PRO) and their measures (PROM) for patient with severe asthma monitoring in clinical practice in Spain. The results of this study offer an approach in the follow-up of severe asthma for the standardized integration of the patient’s perspective into clinical practice, thus contributing to optimize […]
Assessing the value of atopic dermatitis treatment using Multi-Criteria Decision Analysis (MCDA)
MCDA to create an optimal conceptual framework for evaluating novel treatments in moderate-to-severe AD by establishing the most relevant health outcomes (criteria) for decision-making from all stakeholders’ perspectives (patients, clinicians and payers).
Coste-utilidad de la telerrehabilitación cardíaca frente a la rehabilitación hospitalaria convencional tras síndrome coronario agudo en España
Cost-utility analysis based on data collected in a clinical trial conducted at the Hospital Arnau de Vilanova (Valencia). The trial compared cardiac telerehabilitation with conventional hospital rehabilitation. The analysis was conducted from the perspective of the National Health System and society.
Therapeutic management of allergic rhinitis: a survey of otolaryngology and allergology specialists
This short communication sets out in the context of the publication of the Next-generation ARIA guidelines and the need to improve the therapeutic control of AR patients in our settings. Therefore, this work describe how the management of AR by specialists (otolaryngologists and allergists) is according to new guidelines in the Spanish Public and Private […]
